WEHI has been awarded a $2.5 million grant from the Australian Cancer Research Foundation to launch the ACRF BRAIINSTORM Program – a landmark national initiative that will fast-track new personalised treatments for high-grade gliomas, the most aggressive and deadly brain cancers in both children and adults.
Brain cancers remain the leading cause of childhood cancer death in Australia, and DIPG is the deadliest tumour type.
In adults, the initiative will target glioblastoma, which claims 65% of all brain cancer deaths and still has no effective long-term treatment.
The BRAIINSTORM program is co-led by Professor Misty Jenkins AO and Dr Jim Whittle, WEHI laboratory heads and co-heads of Research Strategy at The Brain Cancer Centre.